RxDoctor Payments Data

Amy van Dusen

Medical · Riverview, MINPI 1942520119

Payments from drug & device makers

$5,791in general payments, 2019–2025

Across 332 payments — averaging $17.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Collegium Pharmaceutical, Inc.$574
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$551
  • Nevro Corp.$330
  • Globus Medical$313
  • Amgen$281
  • plus $2K from 26 others

What the payments were for

  • Food & beverage$5,791100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,791 in reported general payments places this provider in the 85th percentile of 755 medical providers in Michigan.

See all medical providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
BelbucaBuprenorphine Hcl55$33,353
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl211$23,456
Buprenorphine66$18,125
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,217$16,630
Pregabalin349$12,548
MovantikNaloxegol Oxalate23$10,716
Gabapentin377$9,734
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen553$9,053
Fentanyl109$7,724
SuboxoneBuprenorphine Hcl/Naloxone Hcl19$5,197
Morphine Sulfate ErMorphine Sulfate152$3,705
Lidocaine27$2,257
Tizanidine Hcl84$1,231
Oxycodone Hcl69$1,046
Duloxetine Hcl28$982

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Collegium Pharmaceutical, Inc.Belbuca$574$33,35355 claims
Redhill Biopharma Inc.Movantik$65$10,71623 claims
Indivior Inc.Suboxone$33$5,19719 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 755 medical providers in Michigan.

Other medical in Riverview

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →